Application

18248205 · BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDITIONS

Filed 2023-04-06 · Pending The official file ↗ · Art unit 1644 · Examiner James Ryland Melchior Easy · CPC C07K 16/2803 · CELGENE CORPORATION · Celgene Corporation

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

32.6 mo

to disposition n/a

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.